|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
5R01CA204586-03
|
$416,268
|
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
$74,840
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$531,469
|
|
Gonzalez, Frank
|
CCR (NCI)
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
$70,220
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Weight cycling and total and site-specific cancer incidence and mortality
|
5R03CA204825-02
|
$79,500
|
|
GIOVANNUCCI, EDWARD
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Weekly Symptom Telemanagement in Advanced Lung Cancer
|
5R01CA115361-03
|
$340,494
|
$340,494
|
Yount, Susan
|
EVANSTON NORTHWESTERN HEALTHCARE
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
5F31CA213901-02
|
$44,524
|
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Virtual Transportation as a Strategy to Reduce Resistance to Cigarette and e-Cigarette Graphic Health Warnings in Adolescents and Young Adults
|
5R01CA214587-03
|
$363,195
|
|
BLANTON, HART
|
TEXAS A&M UNIVERSITY
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$17,600
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$86,020
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-03
|
$341,981
|
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VCU Minority-Based CCOP
|
3U10CA052784-17S1
|
$100,000
|
$18,000
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-17
|
$527,332
|
$94,920
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,186,781
|
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Variations of care in older men with prostate cancer
|
5R03CA121338-02
|
$76,365
|
$19,091
|
JAYADEVAPPA, RAVISHANKAR
|
UNIVERSITY OF PENNSYLVANIA
|
|
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases
|
2R42CA206744-02A1
|
$665,919
|
|
MCCABE, AARON
|
MINNETRONIX, INC.
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
4UH3CA206124-03
|
$423,750
|
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validation and translation of a non-invasive, MR-guided breast cancer therapy
|
1R37CA224141-01
|
$513,511
|
|
PAYNE, ALLISON
|
UNIVERSITY OF UTAH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-07
|
$641,991
|
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$532,008
|
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$532,008
|
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-34
|
$4,748,000
|
$189,920
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S1
|
$56,723
|
$2,269
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S2
|
$239,556
|
$9,582
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UTMB Center for Population Health and Health Disparities
|
5P50CA105631-05
|
$1,622,797
|
$1,622,797
|
GOODWIN, JAMES
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Utilizing Nucleic-Acid Scavengers to Ameliorate Inflammation-driven Metastatic Progression in Breast Cancer
|
1F31CA232394-01
|
$35,885
|
|
ETESHOLA, ELIAS
|
DUKE UNIVERSITY
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$40,866
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients
|
5R01CA193706-03
|
$554,574
|
$554,574
|
WYATT, GWEN
|
MICHIGAN STATE UNIVERSITY
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
5R21CA208921-02
|
$167,475
|
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
Using Physiological Age to Predict Chemotherapy Toxicity
|
1R01CA124924-01
|
$611,423
|
$611,423
|
MANDELBLATT, JEANNE
|
GEORGETOWN UNIVERSITY
|
|
Using patient-derived models to understand drug responses in SCLC
|
1U01CA220323-01A1
|
$619,923
|
|
DYSON, NICHOLAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-05
|
$323,700
|
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy Women
|
1K07CA221899-01A1
|
$129,704
|
|
GUNN, CHRISTINE
|
BOSTON MEDICAL CENTER
|
|
Use of Opiod Titration Orders in Cancer Pain Treatment
|
5R01CA095413-04
|
$267,363
|
$133,682
|
WELLS, NANCY
|
VANDERBILT UNIVERSITY
|
|
Use of Alternative Tobacco Products Among Homeless Youth
|
5R01CA204004-02
|
$291,072
|
|
TUCKER, JOAN
|
RAND CORPORATION
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-32
|
$6,578,401
|
$328,920
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
$400,390
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
University of the District of Columbia and the Lombardi*
|
5U56CA101429-05
|
$365,451
|
$91,363
|
SHIELDS, PETER
|
GEORGETOWN UNIVERSITY
|
|
University of Texas PDX Development and Trial Center
|
3U54CA224065-01S1
|
$175,000
|
|
ROTH, JACK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-23S1
|
$146,724
|
$44,017
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-23
|
$1,131,018
|
$339,305
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S2
|
$59,280
|
$2,371
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S3
|
$114,000
|
$4,560
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-20
|
$5,929,129
|
$237,165
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
$589
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Iowa CALGB Institutional Grant
|
5U10CA047642-20
|
$119,291
|
$25,051
|
VAENA, DANIEL
|
UNIVERSITY OF IOWA
|
|
University of Colorado Southwest Oncology Group
|
2U10CA042777-20
|
$82,102
|
$24,631
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
University of Colorado Southwest Oncology Group
|
3U10CA042777-20S1
|
$356,613
|
$106,984
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
|
1U54CA233306-01
|
$6,160,778
|
|
PAN, CHONG-XIAN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S1
|
$68,952
|
$2,758
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
Total relevant funding to Cancer Survivorship for this search: $215,473,563
|